Rational design of non-toxic GOx-based biocatalytic nanoreactor for multimodal synergistic therapy and tumor metastasis suppression
Lifeng Hang,Tao Zhang,Hua Wen,Meng Li,Lianbao Liang,Xinfeng Tang,Chunze Zhou,JunZhang Tian,Xiaofen Ma,Guihua Jiang
DOI: https://doi.org/10.7150/thno.65399
IF: 11.6
2021-01-01
Theranostics
Abstract:<b>Rationale:</b> Glucose oxidase (GOx)-based biocatalytic nanoreactors can cut off the energy supply of tumors for starvation therapy and deoxygenation-activated chemotherapy. However, these nanoreactors, including mesoporous silica, calcium phosphate, metal-organic framework, or polymer nanocarriers, cannot completely block the reaction of GOx with glucose in the blood, inducing systemic toxicity from hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and anoxia. The low enzyme loading capacity can reduce systemic toxicity but limits its therapeutic effect. Here, we describe a real 'ON/OFF' intelligent nanoreactor with a core-shell structure (GOx + tirazapamine (TPZ))/ZIF-8@ZIF-8 modified with the red cell membrane (GTZ@Z-RBM) for cargo delivery. <b>Methods:</b> GTZ@Z-RBM nanoparticles (NPs) were prepared by the co-precipitation and epitaxial growth process under mild conditions. The core-shell structure loaded with GOx and TPZ was characterized for hydrate particle size and surface charge. The GTZ@Z-RBM NPs morphology, drug, and GOx loading/releasing abilities, system toxicity, multimodal synergistic therapy, and tumor metastasis suppression were investigated. The <i>in vitro</i> and <i>in vivo</i> outcomes of GTZ@Z-RBM NPs were assessed in 4T1 breast cancer cells. <b>Results:</b> GTZ@Z-RBM NPs could spatially isolate the enzyme from glucose in a physiological environment, reducing systemic toxicity. The fabricated nanoreactor with high enzyme loading capacity and good biocompatibility could deliver GOx and TPZ to the tumors, thereby exhausting glucose, generating H<sub>2</sub>O<sub>2</sub>, and aggravating hypoxic microenvironment for starvation therapy, DNA damage, and deoxygenation-activated chemotherapy. Significantly, the synergistic therapy effectively suppressed the breast cancer metastasis in mice and prolonged life without systemic toxicity. The <i>in vitro</i> and <i>in vivo</i> results provided evidence that our biomimetic nanoreactor had a powerful synergistic cascade effect in treating breast cancer. <b>Conclusion:</b> GTZ@Z-RBM NPs can be used as an 'ON/OFF' intelligent nanoreactor to deliver GOx and TPZ for multimodal synergistic therapy and tumor metastasis suppression.
medicine, research & experimental